Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 4
Submit an article Journal homepage
473
Views
13
CrossRef citations to date
0
Altmetric
Letter to the Editor

Acute myeloid leukemia in Jehovah Witnesses

Nicole M. Brown Pennsylvania Oncology Hematology Associates, 230 W. Washington Square, Philadelphia, PA, USA
,
Gina Keck Pennsylvania Oncology Hematology Associates, 230 W. Washington Square, Philadelphia, PA, USA
&
Patricia A. Ford Pennsylvania Oncology Hematology Associates, 230 W. Washington Square, Philadelphia, PA, USACorrespondence[email protected]
Pages 817-820 | Received 26 Nov 2007, Accepted 10 Jan 2008, Published online: 01 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stefan Wilop & Rainhardt Osieka. (2018) Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products – a matched pair analysis. Hematology 23:6, pages 324-329.
Read now

Articles from other publishers (12)

Nina Nguyen, Ellen Madarang, Alvaro Alencar, Justin Watts & Terrence Bradley. (2022) The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. Leukemia Research Reports 18, pages 100355.
Crossref
Allison M. Bock & Daniel A. Pollyea. (2020) Venetoclax with azacitidine for two younger Jehovahʼs Witness patients with high risk acute myeloid leukemia. American Journal of Hematology 95:10.
Crossref
Firas El Chaer & Karen K. Ballen. (2019) Treatment of acute leukaemia in adult Jehovah's Witnesses. British Journal of Haematology 190:5, pages 696-707.
Crossref
Rory M. Shallis, Mina L. Xu, Susanna A. Curtis, Erin Medoff, Rose Mixon, Anna Folkers & Amer M. Zeidan. (2018) Conviction in the face of affliction: a case series of Jehovah’s Witnesses with myeloid malignancies. Annals of Hematology 97:11, pages 2245-2248.
Crossref
Carlton D. Scharman, Debora Burger, Joseph J. Shatzel, Edward Kim & Thomas G. DeLoughery. (2017) Treatment of individuals who cannot receive blood products for religious or other reasons. American Journal of Hematology 92:12, pages 1370-1381.
Crossref
Krzysztof Chojnowski, Agnieszka JanusKatarzyna BliźniewskaMarta Robak & Jacek Treliński. (2016) Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. Transfusion 56:10, pages 2438-2442.
Crossref
Daniela Cárdenas-Araujo, Elías Eugenio González-López, Xitlaly Judith González-Leal, José Carlos Jaime-Pérez & David Gómez-Almaguer. (2016) A clinical challenge: Treatment of acute myeloid leukemia in a Jehovah's Witness. Revista Brasileira de Hematologia e Hemoterapia 38:4, pages 358-360.
Crossref
Ashkan Emadi, Najeebah Bade, Brandi Stevenson & Zeba Singh. (2016) Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia. Pharmaceuticals 9:1, pages 12.
Crossref
Hege Garelius, Sofia Grund & Dick Stockelberg. (2015) Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia. Clinical Case Reports 3:5, pages 287-290.
Crossref
Yumi Yamamoto, Akihito Kawashima, Eri Kashiwagi & Kiyoyuki Ogata. (2014) A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions. Case Reports in Hematology 2014, pages 1-4.
Crossref
Lynn Boshkov. 2012. Textbook of Clinical Pediatrics. Textbook of Clinical Pediatrics 3055 3060 .
Sung Yong Oh, Sung-Hyun Kim, Hyuk-Chan Kwon, Suee Lee, Kyeong Hee Kim, Kyung A Kwon, Jong-Hwan Lee, Kyu-Yeol Lee & Hyo-Jin Kim. (2009) Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. Supportive Care in Cancer 18:10, pages 1341-1346.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.